Clinical Study

Recombinant Brain Natriuretic Peptide for the Prevention of Contrast-Induced Nephropathy in Patients with Chronic Kidney Disease Undergoing Nonemergent Percutaneous Coronary Intervention or Coronary Angiography: A Randomized Controlled Trial

Table 3

Univariate and multivariate analyses of CIN predictors.

VariablesUnivariate odds ratio (95% CI) valueMultivariate odds ratio (95% CI) value

Age3.08 (2.23, 4.29)0.0230.86 (0.62, 0.98)0.344
Diabetes mellitus4.71 (4.04, 6.13)0.0112.12 (1.08, 3.66)0.083
Hypertension2.96 (1.75, 5.17)0.0311.13 (0.61, 2.07)0.184
Contrast volume >100 mL5.32 (4.13, 6.65)0.0024.36 (2.23, 5.47)0.004
Type of procedure3.48 (2.06, 4.12)0.0141.04 (0.61, 4.14)0.321
BNP administration6.27 (4.46, 8.23)<0.0010.21 (0.09, 0.46)0.006

.